All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance

Download All
Hear from experts on the burden of extraintestinal pathogenic E coli (ExPEC), risk factors for invasive disease and multidrug resistance, and the evolving vaccine landscape for ExPEC prevention during the live symposia. Reinforce your learning with an on-demand video, downloadable slides, podcast, and expert-authored commentaries highlighting key discussion points about ExPEC.
Lilian Abbo Headshot
Lilian Abbo, MD, FIDSA
Program Director
person default
Julie Ann Justo, PharmD, MS
Program Director
David Van Duin, MD, PhD, FIDSA, FAST
Program Director
Lilian Abbo Headshot
Lilian Abbo, MD, FIDSA
person default
Julie Ann Justo, PharmD, MS
David Van Duin, MD, PhD, FIDSA, FAST

ClinicalThought

Here’s my summary of our current knowledge about extraintestinal pathogenic Escherichia coli and the challenges and opportunities associated with vaccine development for these bacteria.

person default Julie Ann Justo, PharmD, MS Released: August 31, 2022

Preventive measures such as vaccination are strong antimicrobial stewardship tools that need more development so the attention is not focused only on the development of new antibiotics. Here are my thoughts on the current landscape of vaccines against extraintestinal pathogenic Escherichia coli.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA Released: October 6, 2022

Extraintestinal pathogenic E coli (ExPEC) has been around for a long time and will likely remain clinically important in the foreseeable future. Read Dr David van Duin’s thoughts on why this is a concern and what populations are at highest risk for developing ExPEC invasive infections.

David Van Duin, MD, PhD, FIDSA, FAST Released: December 6, 2022

Downloadable Slidesets

Learn about the diverse strains of extraintestinal pathogenic Escherichia coli (ExPEC) including pertinent virulence factors and antimicrobial resistance profiles that cause invasive disease.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA
Program Director
person default Julie Ann Justo, PharmD, MS
Program Director
Released: September 27, 2022

Read about the prevalence of infections caused by extraintestinal pathogenic Escherichia coli (ExPEC) and the populations at highest risk for invasive disease.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA
Program Director
David Van Duin, MD, PhD, FIDSA, FAST
Program Director
Released: September 27, 2022

Review the current landscape of vaccine development targeting extraintestinal pathogenic Escherichia coli (ExPEC) and its potential benefits for invasive disease prevention and mitigation of antibiotic resistance.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA
Program Director
Released: September 27, 2022

On-Demand Webcast

Learn from experts about extraintestinal pathogenic Escherichia coli (ExPEC) concerns, populations at risk for invasive disease and approaches to ExPEC prevention, including an overview of the current landscape of vaccine development.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA
Program Director
person default Julie Ann Justo, PharmD, MS David Van Duin, MD, PhD, FIDSA, FAST
Released: November 3, 2022

Podcast

Listen to expert insights on key concepts of ExPEC, including virulence factors associated with invasive disease, antimicrobial resistance profiles observed in clinical practice, populations at risk for invasive disease, and the current landscape of vaccine development.

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA
Program Director
person default Julie Ann Justo, PharmD, MS David Van Duin, MD, PhD, FIDSA, FAST
Released: October 19, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings